“…We identified 33 preclinical studies published in peer-reviewed journals from 2006 to 2023 relevant to our review. These studies were published in various countries, including China [22,34,35], Egypt [36][37][38][39][40][41][42][43][44], India [24,[45][46][47][48], Iran [20,23,49,50], Indonesia [51], Israel [52], Iraq [53], Malaysia [16,54], Mexico [55], Saudi Arabia [56], Turkey [19,21,57,58], and United States of America [59]. Various methods were used to induce a diabetes model in these preclinical studies, such as the intraperitoneal injection of single streptozotocin (STZ), STZ combined with nicotinamide (NAD), STZ, and high-fat diet, and alloxan monohydrate.…”